<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35551702</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1560-7917</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>19</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title>
          <ISOAbbreviation>Euro Surveill</ISOAbbreviation>
        </Journal>
        <ArticleTitle><i>Mycoplasma pneumoniae</i> detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.2807/1560-7917.ES.2022.27.19.2100746</ELocationID>
        <Abstract>
          <AbstractText>Background<i>Mycoplasma pneumoniae</i> respiratory infections are transmitted by aerosol and droplets in close contact.AimWe investigated global <i>M. pneumoniae</i> incidence after implementation of non-pharmaceutical interventions (NPIs) against COVID-19 in March 2020.MethodsWe surveyed <i>M. pneumoniae</i> detections from laboratories and surveillance systems (national or regional) across the world from 1 April 2020 to 31 March 2021 and compared them with cases from corresponding months between 2017 and 2020. Macrolide-resistant <i>M. pneumoniae</i> (MRMp) data were collected from 1 April 2017 to 31 March 2021.ResultsThirty-seven sites from 21 countries in Europe, Asia, America and Oceania submitted valid datasets (631,104 tests). Among the 30,617 <i>M. pneumoniae</i> detections, 62.39% were based on direct test methods (predominantly PCR), 34.24% on a combination of PCR and serology (no distinction between methods) and 3.37% on serology alone (only IgM considered). In all countries, <i>M. pneumoniae</i> incidence by direct test methods declined significantly after implementation of NPIs with a mean of 1.69% (SD ± 3.30) compared with 8.61% (SD ± 10.62) in previous years (p &lt; 0.01). Detection rates decreased with direct but not with indirect test methods (serology) (-93.51% vs + 18.08%; p &lt; 0.01). Direct detections remained low worldwide throughout April 2020 to March 2021 despite widely differing lockdown or school closure periods. Seven sites (Europe, Asia and America) reported MRMp detections in one of 22 investigated cases in April 2020 to March 2021 and 176 of 762 (23.10%) in previous years (p = 0.04).ConclusionsThis comprehensive collection of <i>M. pneumoniae</i> detections worldwide shows correlation between COVID-19 NPIs and significantly reduced detection numbers.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Meyer Sauteur</LastName>
            <ForeName>Patrick M</ForeName>
            <Initials>PM</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beeton</LastName>
            <ForeName>Michael L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Microbiology and Infection Research Group, Department of Biomedical Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Uldum</LastName>
            <ForeName>Søren A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Bacteria, Parasites and Fungi, Statens Serum Institute, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bossuyt</LastName>
            <ForeName>Nathalie</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Epidemiology of Infectious Diseases, Sciensano, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vermeulen</LastName>
            <ForeName>Melissa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Epidemiology of Infectious Diseases, Sciensano, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Loens</LastName>
            <ForeName>Katherine</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, National Reference Centre for Respiratory Pathogens, University Hospital Antwerp, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pereyre</LastName>
            <ForeName>Sabine</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>UMR CNRS 5234, Fundamental Microbiology and Pathogenicity, University of Bordeaux, Bordeaux, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bébéar</LastName>
            <ForeName>Cécile</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>UMR CNRS 5234, Fundamental Microbiology and Pathogenicity, University of Bordeaux, Bordeaux, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Keše</LastName>
            <ForeName>Darja</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Day</LastName>
            <ForeName>Jessica</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Afshar</LastName>
            <ForeName>Baharak</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chalker</LastName>
            <ForeName>Victoria J</ForeName>
            <Initials>VJ</Initials>
            <AffiliationInfo>
              <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Greub</LastName>
            <ForeName>Gilbert</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nir-Paz</LastName>
            <ForeName>Ran</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Microbiology and Infectious Diseases, Hadassah Hebrew University Medical Center, Jerusalem, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dumke</LastName>
            <ForeName>Roger</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>TU Dresden, University Hospital Carl Gustav Carus, Institute of Medical Microbiology and Virology, Dresden, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>ESGMAC–MyCOVID Study Team</CollectiveName>
            <AffiliationInfo>
              <Affiliation>European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) "Mycoplasma pneumoniae detections before and during the COVID-19 pandemic (MyCOVID)" Study Team members are listed under collaborators.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Sweden</Country>
        <MedlineTA>Euro Surveill</MedlineTA>
        <NlmUniqueID>100887452</NlmUniqueID>
        <ISSNLinking>1025-496X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018942">Macrolides</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018942" MajorTopicYN="N">Macrolides</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009177" MajorTopicYN="N">Mycoplasma pneumoniae</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011019" MajorTopicYN="Y">Pneumonia, Mycoplasma</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Face masks</Keyword>
        <Keyword MajorTopicYN="N">Mycoplasma pneumoniae</Keyword>
        <Keyword MajorTopicYN="N">nonpharmaceutical interventions (NPIs)</Keyword>
        <Keyword MajorTopicYN="N">personal protective equipment (PPE)</Keyword>
        <Keyword MajorTopicYN="N">pneumonia</Keyword>
        <Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)</Keyword>
      </KeywordList>
      <InvestigatorList>
        <Investigator ValidYN="Y">
          <LastName>Wagner</LastName>
          <ForeName>Noémie</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Andreutti</LastName>
          <ForeName>Corinne</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Agyeman</LastName>
          <ForeName>Philipp K A</ForeName>
          <Initials>PKA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Aebi</LastName>
          <ForeName>Christoph</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Buettcher</LastName>
          <ForeName>Michael</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kottanattu</LastName>
          <ForeName>Lisa</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gaia</LastName>
          <ForeName>Valeria</ForeName>
          <Initials>V</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Imkamp</LastName>
          <ForeName>Frank</ForeName>
          <Initials>F</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Zbinden</LastName>
          <ForeName>Reinhard</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Berger</LastName>
          <ForeName>Christoph</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Niederer-Loher</LastName>
          <ForeName>Anita</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Barbey</LastName>
          <ForeName>Florence</ForeName>
          <Initials>F</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Egli</LastName>
          <ForeName>Adrian</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Schmid</LastName>
          <ForeName>Hanna</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Heininger</LastName>
          <ForeName>Ulrich</ForeName>
          <Initials>U</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Papan</LastName>
          <ForeName>Cihan</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kohns Vasconcelos</LastName>
          <ForeName>Malte</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Henrich</LastName>
          <ForeName>Birgit</ForeName>
          <Initials>B</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mackenzie</LastName>
          <ForeName>Colin</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Schneider</LastName>
          <ForeName>Gerlinde</ForeName>
          <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van Westreenen</LastName>
          <ForeName>Mireille</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Verkaik</LastName>
          <ForeName>Nelianne J</ForeName>
          <Initials>NJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van Rossum</LastName>
          <ForeName>Annemarie M C</ForeName>
          <Initials>AMC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Emborg</LastName>
          <ForeName>Hanne-Dorthe</ForeName>
          <Initials>HD</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Peltola</LastName>
          <ForeName>Ville</ForeName>
          <Initials>V</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Renko</LastName>
          <ForeName>Marjo</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Tapiainen</LastName>
          <ForeName>Terhi</ForeName>
          <Initials>T</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Heinonen</LastName>
          <ForeName>Santtu</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Døllner</LastName>
          <ForeName>Henrik</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rodrigues</LastName>
          <ForeName>Fernanda</ForeName>
          <Initials>F</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Matsas</LastName>
          <ForeName>Minos</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kalogera</LastName>
          <ForeName>Eleni</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Petridou</LastName>
          <ForeName>Evangelia</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kopsidas</LastName>
          <ForeName>Ioannis</ForeName>
          <Initials>I</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Zaoutis</LastName>
          <ForeName>Theoklis E</ForeName>
          <Initials>TE</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Michael-Gayego</LastName>
          <ForeName>Ayelet</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Ouchi</LastName>
          <ForeName>Kazunobu</ForeName>
          <Initials>K</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Namkoong</LastName>
          <ForeName>Ho</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hsieh</LastName>
          <ForeName>Yu-Chia</ForeName>
          <Initials>YC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Maiwald</LastName>
          <ForeName>Matthias</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Loo</LastName>
          <ForeName>Liat Hui</ForeName>
          <Initials>LH</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Chaudhry</LastName>
          <ForeName>Rama</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kociolek</LastName>
          <ForeName>Larry K</ForeName>
          <Initials>LK</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rodríguez</LastName>
          <ForeName>Nadia</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Lorenz</LastName>
          <ForeName>David</ForeName>
          <Initials>D</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>De Almeida</LastName>
          <ForeName>Mary</ForeName>
          <Initials>M</Initials>
        </Investigator>
      </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>13</Hour>
          <Minute>47</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35551702</ArticleId>
        <ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.19.2100746</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35551702</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1560-7917</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>19</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title>
          <ISOAbbreviation>Euro Surveill</ISOAbbreviation>
        </Journal>
        <ArticleTitle><i>Mycoplasma pneumoniae</i> detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.2807/1560-7917.ES.2022.27.19.2100746</ELocationID>
        <Abstract>
          <AbstractText>Background<i>Mycoplasma pneumoniae</i> respiratory infections are transmitted by aerosol and droplets in close contact.AimWe investigated global <i>M. pneumoniae</i> incidence after implementation of non-pharmaceutical interventions (NPIs) against COVID-19 in March 2020.MethodsWe surveyed <i>M. pneumoniae</i> detections from laboratories and surveillance systems (national or regional) across the world from 1 April 2020 to 31 March 2021 and compared them with cases from corresponding months between 2017 and 2020. Macrolide-resistant <i>M. pneumoniae</i> (MRMp) data were collected from 1 April 2017 to 31 March 2021.ResultsThirty-seven sites from 21 countries in Europe, Asia, America and Oceania submitted valid datasets (631,104 tests). Among the 30,617 <i>M. pneumoniae</i> detections, 62.39% were based on direct test methods (predominantly PCR), 34.24% on a combination of PCR and serology (no distinction between methods) and 3.37% on serology alone (only IgM considered). In all countries, <i>M. pneumoniae</i> incidence by direct test methods declined significantly after implementation of NPIs with a mean of 1.69% (SD ± 3.30) compared with 8.61% (SD ± 10.62) in previous years (p &lt; 0.01). Detection rates decreased with direct but not with indirect test methods (serology) (-93.51% vs + 18.08%; p &lt; 0.01). Direct detections remained low worldwide throughout April 2020 to March 2021 despite widely differing lockdown or school closure periods. Seven sites (Europe, Asia and America) reported MRMp detections in one of 22 investigated cases in April 2020 to March 2021 and 176 of 762 (23.10%) in previous years (p = 0.04).ConclusionsThis comprehensive collection of <i>M. pneumoniae</i> detections worldwide shows correlation between COVID-19 NPIs and significantly reduced detection numbers.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Meyer Sauteur</LastName>
            <ForeName>Patrick M</ForeName>
            <Initials>PM</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beeton</LastName>
            <ForeName>Michael L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Microbiology and Infection Research Group, Department of Biomedical Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Uldum</LastName>
            <ForeName>Søren A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Bacteria, Parasites and Fungi, Statens Serum Institute, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bossuyt</LastName>
            <ForeName>Nathalie</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Epidemiology of Infectious Diseases, Sciensano, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vermeulen</LastName>
            <ForeName>Melissa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Epidemiology of Infectious Diseases, Sciensano, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Loens</LastName>
            <ForeName>Katherine</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, National Reference Centre for Respiratory Pathogens, University Hospital Antwerp, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pereyre</LastName>
            <ForeName>Sabine</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>UMR CNRS 5234, Fundamental Microbiology and Pathogenicity, University of Bordeaux, Bordeaux, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bébéar</LastName>
            <ForeName>Cécile</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>UMR CNRS 5234, Fundamental Microbiology and Pathogenicity, University of Bordeaux, Bordeaux, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Keše</LastName>
            <ForeName>Darja</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Day</LastName>
            <ForeName>Jessica</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Afshar</LastName>
            <ForeName>Baharak</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chalker</LastName>
            <ForeName>Victoria J</ForeName>
            <Initials>VJ</Initials>
            <AffiliationInfo>
              <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Greub</LastName>
            <ForeName>Gilbert</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nir-Paz</LastName>
            <ForeName>Ran</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Microbiology and Infectious Diseases, Hadassah Hebrew University Medical Center, Jerusalem, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dumke</LastName>
            <ForeName>Roger</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>TU Dresden, University Hospital Carl Gustav Carus, Institute of Medical Microbiology and Virology, Dresden, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>ESGMAC–MyCOVID Study Team</CollectiveName>
            <AffiliationInfo>
              <Affiliation>European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) "Mycoplasma pneumoniae detections before and during the COVID-19 pandemic (MyCOVID)" Study Team members are listed under collaborators.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Sweden</Country>
        <MedlineTA>Euro Surveill</MedlineTA>
        <NlmUniqueID>100887452</NlmUniqueID>
        <ISSNLinking>1025-496X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018942">Macrolides</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018942" MajorTopicYN="N">Macrolides</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009177" MajorTopicYN="N">Mycoplasma pneumoniae</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011019" MajorTopicYN="Y">Pneumonia, Mycoplasma</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Face masks</Keyword>
        <Keyword MajorTopicYN="N">Mycoplasma pneumoniae</Keyword>
        <Keyword MajorTopicYN="N">nonpharmaceutical interventions (NPIs)</Keyword>
        <Keyword MajorTopicYN="N">personal protective equipment (PPE)</Keyword>
        <Keyword MajorTopicYN="N">pneumonia</Keyword>
        <Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)</Keyword>
      </KeywordList>
      <InvestigatorList>
        <Investigator ValidYN="Y">
          <LastName>Wagner</LastName>
          <ForeName>Noémie</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Andreutti</LastName>
          <ForeName>Corinne</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Agyeman</LastName>
          <ForeName>Philipp K A</ForeName>
          <Initials>PKA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Aebi</LastName>
          <ForeName>Christoph</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Buettcher</LastName>
          <ForeName>Michael</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kottanattu</LastName>
          <ForeName>Lisa</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gaia</LastName>
          <ForeName>Valeria</ForeName>
          <Initials>V</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Imkamp</LastName>
          <ForeName>Frank</ForeName>
          <Initials>F</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Zbinden</LastName>
          <ForeName>Reinhard</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Berger</LastName>
          <ForeName>Christoph</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Niederer-Loher</LastName>
          <ForeName>Anita</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Barbey</LastName>
          <ForeName>Florence</ForeName>
          <Initials>F</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Egli</LastName>
          <ForeName>Adrian</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Schmid</LastName>
          <ForeName>Hanna</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Heininger</LastName>
          <ForeName>Ulrich</ForeName>
          <Initials>U</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Papan</LastName>
          <ForeName>Cihan</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kohns Vasconcelos</LastName>
          <ForeName>Malte</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Henrich</LastName>
          <ForeName>Birgit</ForeName>
          <Initials>B</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mackenzie</LastName>
          <ForeName>Colin</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Schneider</LastName>
          <ForeName>Gerlinde</ForeName>
          <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van Westreenen</LastName>
          <ForeName>Mireille</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Verkaik</LastName>
          <ForeName>Nelianne J</ForeName>
          <Initials>NJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van Rossum</LastName>
          <ForeName>Annemarie M C</ForeName>
          <Initials>AMC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Emborg</LastName>
          <ForeName>Hanne-Dorthe</ForeName>
          <Initials>HD</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Peltola</LastName>
          <ForeName>Ville</ForeName>
          <Initials>V</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Renko</LastName>
          <ForeName>Marjo</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Tapiainen</LastName>
          <ForeName>Terhi</ForeName>
          <Initials>T</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Heinonen</LastName>
          <ForeName>Santtu</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Døllner</LastName>
          <ForeName>Henrik</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rodrigues</LastName>
          <ForeName>Fernanda</ForeName>
          <Initials>F</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Matsas</LastName>
          <ForeName>Minos</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kalogera</LastName>
          <ForeName>Eleni</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Petridou</LastName>
          <ForeName>Evangelia</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kopsidas</LastName>
          <ForeName>Ioannis</ForeName>
          <Initials>I</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Zaoutis</LastName>
          <ForeName>Theoklis E</ForeName>
          <Initials>TE</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Michael-Gayego</LastName>
          <ForeName>Ayelet</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Ouchi</LastName>
          <ForeName>Kazunobu</ForeName>
          <Initials>K</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Namkoong</LastName>
          <ForeName>Ho</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hsieh</LastName>
          <ForeName>Yu-Chia</ForeName>
          <Initials>YC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Maiwald</LastName>
          <ForeName>Matthias</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Loo</LastName>
          <ForeName>Liat Hui</ForeName>
          <Initials>LH</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Chaudhry</LastName>
          <ForeName>Rama</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kociolek</LastName>
          <ForeName>Larry K</ForeName>
          <Initials>LK</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rodríguez</LastName>
          <ForeName>Nadia</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Lorenz</LastName>
          <ForeName>David</ForeName>
          <Initials>D</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>De Almeida</LastName>
          <ForeName>Mary</ForeName>
          <Initials>M</Initials>
        </Investigator>
      </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>13</Hour>
          <Minute>47</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35551702</ArticleId>
        <ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.19.2100746</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
